Engineered immune cells prevent type 1 diabetes in mouse study
Researchers at the University of Arizona have adapted a form of cancer immunotherapy to develop a new potential treatment for type 1 diabetes. In mouse studies, the team tweaked immune cells to fight off the rogue T cells that damage insulin-producing … Continue reading Engineered immune cells prevent type 1 diabetes in mouse study
